In Vitro Fertilization (IVF) Clinic Insurance Market Global Report 2026

The in vitro fertilization (IVF) clinic insurance market size has grown strongly in recent years. It will grow from $4.47 billion in 2025 to $4.86 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. Growth during the historic period was supported by the growing number of IVF clinics, the rising incidence of medical malpractice claims, increasing awareness of risk management, the expansion of assisted reproductive technology services, and strengthening healthcare liability regulations.

The in vitro fertilization (IVF) clinic insurance market size is expected to see strong growth in the next few years. It will grow to $6.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the rising demand for cyber liability protection, increasing adoption of digital health platforms, growing investments in fertility healthcare infrastructure, expanding availability of specialized insurance products, and increasing complexity of IVF laboratory operations. Major trends in the forecast period include the growing demand for customized insurance policies for fertility clinics, increasing adoption of cyber risk coverage for patient data protection, rising integration of risk management and compliance advisory services, expanding use of business interruption insurance for IVF laboratory operations, and increasing preference for comprehensive liability insurance packages.

The increasing prevalence of infertility is expected to propel the growth of the in vitro fertilization (IVF) clinic insurance market going forward. Infertility is a medical condition characterized by the inability to achieve pregnancy after 12 months of regular unprotected intercourse or by physical challenges in conceiving or carrying a pregnancy to a live birth. The prevalence of infertility is increasing due to delayed childbearing, as more individuals postpone parenthood until later reproductive years, when age-related declines in egg quality, ovarian reserve, and sperm health reduce the likelihood of successful conception. In vitro fertilization (IVF) clinic insurance helps reduce the financial burden associated with infertility treatments, improves access to assisted reproductive services, supports continuity of care, and enhances opportunities for successful pregnancy outcomes. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people worldwide, experience infertility, emphasizing the urgent need to expand access to affordable, high-quality fertility care. Therefore, the increasing prevalence of infertility is driving the growth of the in vitro fertilization (IVF) clinic insurance market.

The growing adoption of in vitro fertilization (IVF) is expected to propel the growth of the in vitro fertilization (IVF) clinic insurance market going forward. In vitro fertilization (IVF) is an assisted reproductive technology in which an egg is fertilized with sperm outside the body in a laboratory and the resulting embryo is transferred into the uterus to establish pregnancy. The adoption of IVF is increasing due to rising infertility rates driven by lifestyle changes, stress, and underlying health conditions, together with the growing trend of delayed parenthood as individuals prioritize education, career advancement, and financial security before starting families. The growing adoption of in vitro fertilization increases demand for in vitro fertilization (IVF) clinic insurance by expanding treatment volumes, increasing financial and operational risks for clinics, and strengthening the need for comprehensive insurance coverage against procedural, operational, and liability-related risks. For instance, in April 2026, according to the American Society for Reproductive Medicine, a US-based non-profit organization, more than 100,000 infants were born in a single year in the United States through in vitro fertilization (IVF). Therefore, the growing adoption of in vitro fertilization (IVF) is driving the growth of the in vitro fertilization (IVF) clinic insurance market.

Major companies operating in the in vitro fertilization (IVF) clinic insurance market are focusing on developing innovative solutions, such as fertility-specific insurance models, to improve affordability, minimize patients’ financial burden, and expand access to advanced reproductive treatments. Fertility-specific insurance models are specialized health coverage plans designed to cover or subsidize fertility treatments, including IVF, IUI, and related reproductive services that are often excluded from conventional health insurance policies. For instance, in October 2024, Flora Fertility Inc., a Canada-based insurtech company, secured $1.5 million in pre-seed funding to develop and expand its private fertility insurance product across the United States and Canada. The company’s solution introduces an individually owned fertility insurance model that leverages advanced actuarial methods and data-driven risk assessment to provide personalized coverage for patients undergoing fertility treatments. This approach is intended to make IVF and related reproductive services more financially accessible while addressing gaps in traditional insurance systems that do not adequately cover fertility care. The development highlights the increasing integration of specialized insurance innovations within the reproductive healthcare and IVF services ecosystem.

Major companies operating in the in vitro fertilization (ivf) clinic insurance market are Zurich Insurance Group, Chubb Limited, Liberty Mutual Insurance, American International Group (AIG), CNA Financial Corporation, Sompo International, Markel Group Inc., AXA XL, Tokio Marine HCC, Beazley plc, ProAssurance Corporation, MedPro Group, Coverys, The Doctors Company, Avant Mutual, MagMutual Insurance Company, Medical Insurance Exchange of California (MIEC), REI Insurance Solutions LLC, Allianz Commercial, Hiscox Ltd.,NORCAL Group, The Hartford Insurance Group.

North America was the dominating region in the in vitro fertilization (IVF) clinic insurance market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro fertilization (IVF) clinic insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro fertilization (IVF) clinic insurance market includes revenues earned by entities through equipment and operational risk protection, legal claim settlements, and risk management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

This product will be delivered within 3-5 business days.